Amgen Inc. buy Scotiabank
Start price
13.11.25
/
50%
€292.00
Target price
13.11.26
€332.22
Performance (%)
-3.77%
Price
13.01.26
€278.60
Summary
This prediction is currently active. With a performance of -3.77%, the BUY prediction for Amgen Inc. by Scotiabank is down slightly. Dividends of €2.38 are taken into consideration when calculating the performance. This prediction currently runs until 13.11.26. The prediction end date can be changed by Scotiabank at any time. Scotiabank has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | -1.363% | -1.363% |
| iShares Core DAX® | 1.644% | 4.865% |
| iShares Nasdaq 100 | 0.747% | 2.923% |
| iShares Nikkei 225® | 2.442% | 6.212% |
| iShares S&P 500 | 0.618% | 2.843% |
Comments by Scotiabank for this prediction
In the thread Amgen Inc. diskutieren
Amgen (NASDAQ:AMGN) is now covered by analysts at Scotiabank. They set an "outperform" rating and a $385.00 price target on the stock.
Ratings data for AMGN provided by MarketBeat